Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421K Sell
3,500
-625
-15% -$72.2K 0.14% 85
2025
Q4
$434K Sell
4,125
-250
-6% -$23.5K 0.14% 84
2025
Q3
$367K Sell
4,375
-1,875
-30% -$154K 0.13% 89
2025
Q2
$495K Sell
6,250
-1,250
-17% -$99.4K 0.21% 69
2025
Q1
$673K Sell
7,500
-500
-6% -$46.7K 0.34% 61
2024
Q4
$796K Sell
8,000
-2,500
-24% -$258K 0.31% 70
2024
Q3
$1.19M Sell
10,500
-625
-6% -$74.3K 0.54% 54
2024
Q2
$1.38M Sell
11,125
-750
-6% -$96.6K 0.7% 43
2024
Q1
$1.57M Sell
11,875
-750
-6% -$92.4K 0.75% 40
2023
Q4
$1.38M Buy
12,625
+6,625
+110% +$688K 0.58% 50
2023
Q3
$618K Sell
6,000
-625
-9% -$67.4K 0.38% 55
2023
Q2
$764K Sell
6,625
-1,125
-15% -$128K 0.43% 50
2023
Q1
$825K Sell
7,750
-3,125
-29% -$337K 0.46% 49
2022
Q4
$1.21M Sell
10,875
-1,000
-8% -$102K 0.69% 42
2022
Q3
$1.02M Sell
11,875
-5,875
-33% -$524K 0.62% 48
2022
Q2
$1.62M Sell
17,750
-8,250
-32% -$731K 0.86% 37
2022
Q1
$2.13M Sell
26,000
-11,500
-31% -$907K 0.84% 34
2021
Q4
$2.87M Sell
37,500
-5,750
-13% -$458K 1.19% 28
2021
Q3
$3.25M Sell
43,250
-25,500
-37% -$1.94M 1.4% 24
2021
Q2
$5.35M Buy
68,750
+41,502
+152% +$3.09M 2.69% 13
2021
Q1
$2M Buy
27,248
+14,410
+112% +$1.06M 1.12% 33
2020
Q4
$1M Buy
+12,838
New +$982K 0.59% 44
2020
Q1
Sell
-3,668
Closed -$318K 59
2019
Q4
$318K Hold
3,668
0.18% 52
2019
Q3
$295K Sell
3,668
-524
-13% -$42K 0.14% 56
2019
Q2
$335K Sell
4,192
-933
-18% -$71.4K 0.19% 48
2019
Q1
$407K Sell
5,125
-1,425
-22% -$107K 0.2% 50
2018
Q4
$478K Sell
6,550
-1,572
-19% -$111K 0.22% 51
2018
Q3
$550K Sell
8,122
-9,956
-55% -$634K 0.2% 58
2018
Q2
$1.05M Sell
18,078
-262
-1% -$14.8K 0.45% 45
2018
Q1
$953K Buy
+18,340
New +$991K 0.42% 49

Other funds holding MRK

Game Creek Capital's MRK Position: Q1 2026 in Review

Game Creek Capital reduced its Merck (MRK) stake by 15% in Q1 2026, selling an estimated $72.2K and leaving 3,500 shares worth $421K. The position accounts for 0.14% of the portfolio, ranked #85.

Game Creek Capital first reported a position in MRK in Q1 2018 and has held it in 30 quarters since. The position peaked at $5.35M in Q2 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Game Creek Capital held 3,500 shares of Merck worth $421K as of Q1 2026.
  • Game Creek Capital sold 625 Merck shares in Q1 2026, an estimated $72.2K.
  • Merck made up 0.14% of Game Creek Capital's portfolio in Q1 2026, its #85 holding.
  • Game Creek Capital first reported a position in Merck in Q1 2018 and has held it in 30 quarters since.
  • Game Creek Capital's Merck position peaked at $5.35M in Q2 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.